Sign In
Buy CYDY
$0.276
-0.0143 (-4.93%)
At Close: Jun 03, 2026
Shareholder Alert: Robbins LLP is Investigating CytoDyn Inc. (CYDY) on Behalf of Shareholders
04:48pm, Friday, 19'th Mar 2021
SAN DIEGO & VANCOUVER, Wash.--(BUSINESS WIRE)---- $CYDY #ShareholderRights--Shareholder rights law firm Robbins LLP is investigating CytoDyn Inc. (OTC: CYDY) on behalf of shareholders to determine whe
BENSALEM, Pa.--(BUSINESS WIRE)---- $CYDY #CLASSACTION--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased CytoDyn, Inc. (“CytoDy
New York, New York--(Newsfile Corp. - March 18, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of C
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY
09:29pm, Thursday, 18'th Mar 2021
NEW YORK, March 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CytoDyn Inc. ("CytoDyn" or the "Company") (OTCMKTS: CYDY). Such investors are advised to
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2021 to file
NEW YORK--(BUSINESS WIRE)-- #ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States Di
Notice of Lead Plaintiff Deadline for Shareholders in the CytoDyn, Inc. Class Action Lawsuit
05:00pm, Thursday, 18'th Mar 2021
SAN DIEGO--(BUSINESS WIRE)-- #CYDYstock--The suit alleges defendants issued false statements concerning CytoDyn business and prospects, resulting in its stock trading at inflated prices.
NEW YORK, March 18, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against CytoDyn, Inc. ("CytoDyn" or
A New Look At CytoDyn's Severe-To-Critical COVID-19 Trial
04:39pm, Wednesday, 17'th Mar 2021
Trial data is supportive of an EUA: Leronlimab outperformed every approved or recommended drug in critically ill patients. Shorts have a flawed analysis that doesn't correct for patient age distributi
CytoDyn appoints new chief operating officer
11:23am, Tuesday, 16'th Mar 2021
CytoDyn Inc (OTCQB:CYDY) said it has appointed Christopher P. Recknor as its chief operating officer to assist the senior management team in defining and implementing the company's overall business st
Wall Street off to a mixed start on Tuesday
11:23am, Tuesday, 16'th Mar 2021
10.30am: Proactive North America headlines: Neo Lithium Corp (CVE:NLC) (OTCQX:NTTHF) (FRA:NE2) closes its C$2.6M equity financing with Chinese investor CATL GlobeX Data Ltd (OTCQB:SWISF) (CSE:SWIS) re
CytoDyn Appoints Christopher Recknor, M.D., as Chief Operating Officer
06:00am, Tuesday, 16'th Mar 2021
Dr. Recknor will continue to oversee the Company's COVID-19 long-haulers and Phase 2 NASH trials
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY
08:44pm, Sunday, 14'th Mar 2021
New York, New York--(Newsfile Corp. - March 14, 2021) - Pomerantz LLP is investigating claims on behalf of investors of CytoDyn Inc. ("CytoDyn" or the "Company") (OTCQB: CYDY). Such investors are advi
Kessler Topaz Meltzer & Check, LLP Is Investigating Securities Fraud Claims on Behalf of CytoDyn Inc. (OTCMKTS: CYDY) Investors
11:36am, Friday, 12'th Mar 2021
RADNOR, Pa.--(BUSINESS WIRE)---- $CYDY #classaction--Kessler Topaz Meltzer & Check, LLP Investigates CytoDyn Inc. for Potential Violations of federal securities laws on behalf of investors.
CytoDyn: Far From Failure
10:30am, Friday, 12'th Mar 2021
CytoDyn's drug leronlimab (PRO-140) is not a failure. Bears are dismissing the efficacy of the drug by focusing solely on the shortcomings of management.
